Grith Hagel
Founder chez 2CUREX AB
Profil
Grith Hagel is the founder of 2cureX ApS, where she holds the title of Head-Project Management since 2011.
She is also the founder of 2cureX AB, where she holds the title of Vice President-Innovation.
Ms. Hagel is also the founder of Noapab Holdings A..
Ms. Hagel's former jobs include being a Principal at Novo Nordisk A and Carlsberg A.
Postes actifs de Grith Hagel
Sociétés | Poste | Début |
---|---|---|
2CUREX AB | Founder | 01/01/2006 |
2cureX ApS
2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark. | Founder | 07/04/2010 |
Anciens postes connus de Grith Hagel
Sociétés | Poste | Fin |
---|---|---|
CARLSBERG A/S | Corporate Officer/Principal | - |
Noapab Holdings A/S | Founder | - |
NOVO NORDISK A/S | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 3 |
---|---|
NOVO NORDISK A/S | Health Technology |
CARLSBERG A/S | Consumer Non-Durables |
2CUREX AB | Health Technology |
Entreprise privées | 2 |
---|---|
Noapab Holdings A/S | Commercial Services |
2cureX ApS
2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark. | Health Technology |